About Dishman Carbogen Amcis Ltd
Dishman Carbogen Amcis is engaged in Contract Development and Manufacturing Organisation (CDMO) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins& chemicals and disinfectants. The equity shares of Dishman Carbogen Amcis Limited are listed on National Stock Exchange of India Ltd.
Founded
2007
CEO
N/A
Employees
1,789
HQ
Gujarat, India
Finished Products
1Sale of Products
₹615.43Cr2Business Support Services
₹36.66Cr3Other Operating Income
₹30.50Cr4Forex Gain on Forward Contract
₹18.09Cr5Sale of Raw Maerial
₹12.58Cr6Sale of Services
₹11.57Cr7Sale of Scrap
₹1.21Cr1–7 of 8
Raw Materials
1Raw Material Consumed
₹224.71CrAbout Dishman Carbogen Amcis Ltd
Dishman Carbogen Amcis is engaged in Contract Development and Manufacturing Organisation (CDMO) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins& chemicals and disinfectants. The equity shares of Dishman Carbogen Amcis Limited are listed on National Stock Exchange of India Ltd.
Founded:2007
CEO:N/A
Employees:1,789
HQ:Gujarat, India
Finished Products
1Sale of Products
₹615.43Cr2Business Support Services
₹36.66Cr3Other Operating Income
₹30.50Cr4Forex Gain on Forward Contract
₹18.09Cr5Sale of Raw Maerial
₹12.58Cr6Sale of Services
₹11.57Cr7Sale of Scrap
₹1.21Cr1–7 of 8
Raw Materials
1Raw Material Consumed
₹224.71CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹322
52W Low
₹129
Volume225.33K
Avg VolumeN/A
Beta1.81
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
171.84x
Valuation
P/B Ratio
0.42x
Valuation
EPS
₹1.03
Valuation
Dividend Yield
0.00%
Valuation
ROE
1.46%
Profitability
ROCE
2.66%
Profitability
Revenue by Segment
Contribution & growth by business line
CRAMS
+15.1%77.0%
₹1,649.34 Cr
Vitamin-D, Bulk Drugs, Quats, Spec
+2.4%23.0%
₹491.35 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
1.7%
International
98.3%
Rest of the world98.3%
India1.7%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.46x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
4.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.